Surgical Co. Investors Nab $7M Settlement In Stock-Drop Suit
Staar Surgical Co., accused by investors of wrongly downplaying the U.S. Food and Drug Administration's concerns about its manufacturing practices, has reached a $7 million deal to end the litigation, according...To view the full article, register now.
Already a subscriber? Click here to view full article